Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular response
Saved in:
| Title: | Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular response |
|---|---|
| Authors: | Yhim, Ho-Young1, Lee, Na-Ri1,2, Song, Eun-Kee1,2, Yim, Chang-Yeol1,2, Jeon, So Yeon1, Shin, Seunghwan3, Kim, Jeong-A3, Kim, Hee Sun4, Cho, Eun Hae5, Kwak, Jae-Yong1,2 jykwak@jbnu.ac.kr |
| Source: | Leukemia Research. Jun2012, Vol. 36 Issue 6, p689-693. 5p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 74499411 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular response – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Yhim%2C+Ho-Young%22">Yhim, Ho-Young</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Lee%2C+Na-Ri%22">Lee, Na-Ri</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Song%2C+Eun-Kee%22">Song, Eun-Kee</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Yim%2C+Chang-Yeol%22">Yim, Chang-Yeol</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Jeon%2C+So+Yeon%22">Jeon, So Yeon</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Shin%2C+Seunghwan%22">Shin, Seunghwan</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Kim%2C+Jeong-A%22">Kim, Jeong-A</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Kim%2C+Hee+Sun%22">Kim, Hee Sun</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Cho%2C+Eun+Hae%22">Cho, Eun Hae</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Kwak%2C+Jae-Yong%22">Kwak, Jae-Yong</searchLink><relatesTo>1,2</relatesTo><i> jykwak@jbnu.ac.kr</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Leukemia+Research%22">Leukemia Research</searchLink>. Jun2012, Vol. 36 Issue 6, p689-693. 5p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=74499411 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.leukres.2012.02.011 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 5 StartPage: 689 Titles: – TitleFull: Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular response Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yhim, Ho-Young – PersonEntity: Name: NameFull: Lee, Na-Ri – PersonEntity: Name: NameFull: Song, Eun-Kee – PersonEntity: Name: NameFull: Yim, Chang-Yeol – PersonEntity: Name: NameFull: Jeon, So Yeon – PersonEntity: Name: NameFull: Shin, Seunghwan – PersonEntity: Name: NameFull: Kim, Jeong-A – PersonEntity: Name: NameFull: Kim, Hee Sun – PersonEntity: Name: NameFull: Cho, Eun Hae – PersonEntity: Name: NameFull: Kwak, Jae-Yong IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: Jun2012 Type: published Y: 2012 Identifiers: – Type: issn-print Value: 01452126 Numbering: – Type: volume Value: 36 – Type: issue Value: 6 Titles: – TitleFull: Leukemia Research Type: main |
| ResultId | 1 |